Is Anuh Pharma Ltd debt-free?

Yes, Anuh Pharma Ltd is debt-free with a debt-to-equity ratio of 0.03.

Home

Anuh Pharma Ltd

Anuh Pharma Ltd Financials

Anuh Pharma Ltd Financial Statement

Anuh Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2025	Jun 2025	Mar 2025
Revenue	186.86	189.87	199.54
Operating Expense	174	176.19	179.47
Net Profit	7.61	8.30	12.46
Net Profit Margin	4.07	4.37	6.24
Earning Per Share	0.76	1.66	2.49
EBIDTA	13.35	13.52	20.67
Effective Tax Rate	21.77	18.20	27.01

Particulars	Sep 2025
Revenue	186.86
Operating Expense	174.00
Net Profit	7.61
Net Profit Margin	4.07
Earning Per Share	0.76
EBIDTA	13.35
Effective Tax Rate	21.77

Anuh Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	661.51	647.00	527.49
Operating Expenses Annual	600.61	571.86	476.21
Operating Profit Annual	70.36	87.25	57.39
Interest Annual	0.62	0.35	0.22
Depreciation	8.74	8.58	9.70
Net Profit Annual	47.35	60.06	36.18
Tax Annual	13.65	18.25	11.29

Particulars	Mar 2025
Total Revenue Annual	661.51
Operating Expenses Annual	600.61
Operating Profit Annual	70.36
Interest Annual	0.62
Depreciation	8.74
Net Profit Annual	47.35
Tax Annual	13.65

Anuh Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	7.20	1.93	3.80
Cash Flow from Operations	37.12	12.93	53.90
Cash Flow from Investing	-19.91	0.92	-43.48
Cash Flow from Financing	-4.86	-8.57	-12.29
Cash Flow at the End	19.56	7.20	1.93

Particulars	Mar 2025
Cash Flow at the Beginning	7.20
Cash Flow from Operations	37.12
Cash Flow from Investing	-19.91
Cash Flow from Financing	-4.86
Cash Flow at the End	19.56

Anuh Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	9.54	11.92	10.98
PBIT Margin (%)	8.22	10.60	9.14
PBT Margin (%)	1.59	-0.44	-3.05
Net PROFIT Margin (%)	7.16	9.28	6.86
Return On Networth / Equity (%)	13.41	19.49	15.90
Return On Networth /Employed (%)	17.15	25.44	20.82
Return On Assets (%)	14.96	22.28	15.64
Total Debt / Equity (X)	0.02	0.01	0.01
Asset Turnover Ratio (%)	2.09	2.40	2.28

Particulars	Mar 2025
PBDIT Margin (%)	9.54
PBIT Margin (%)	8.22
PBT Margin (%)	1.59
Net PROFIT Margin (%)	7.16
Return On Networth / Equity (%)	13.41
Return On Networth /Employed (%)	17.15
Return On Assets (%)	14.96
Total Debt / Equity (X)	0.02
Asset Turnover Ratio (%)	2.09

Anuh Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	58.21	48.95	52.81
Total Current Assets Annual	376.17	338.54	307.61
Non Current Assets Annual	130.46	107.14	97.37
Total Shareholders Funds Annual	326.02	291.22	241.22
Total Assets Annual	506.63	445.68	404.98

Particulars	Mar 2025
Fixed Assets Annual	58.21
Total Current Assets Annual	376.17
Non Current Assets Annual	130.46
Total Shareholders Funds Annual	326.02
Total Assets Annual	506.63

Anuh Pharma Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Anuh Pharma Ltd Financials

As of Nov 27, 2025, Anuh Pharma Ltd has a market capitalization of 745.92 Cr. Value Research classifies it as a Small-Cap company.

Yes, Anuh Pharma Ltd is with a debt-to-equity ratio of 0.03.

In FY 2024 , Anuh Pharma Ltd recorded a total revenue of approximately 661.51 Cr marking a significant milestone in the company's financial performance.

Anuh Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

Anuh Pharma Ltd's current PE ratio is 15.75.

Anuh Pharma Ltd's ROCE averaged 21.6% from the FY ending March 2023 to 2025, with a median of 19.7%. It peaked at 26.8% in March 2024, reflecting strong capital efficiency over the period..

Anuh Pharma Ltd's latest EBIT is Rs. 61.63 Cr, surpassing the average EBIT of Rs. 62.66 Cr over the 5 years..